Targeting polymerase θ impairs tumorigenesis and enhances radiosensitivity in lung adenocarcinoma
Cancer Science · 2023
DOI: 10.1111/cas.15727 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, 2023. Verfasst von Xinrui Rao und 16 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Adenocarcinoma of Lung. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Radioresistance remains a major obstacle to efficacious radiotherapy in non–small‐cell lung cancer (NSCLC). DNA replication proteins are novel targets for radiosensitizers. POLQ is a DNA polymerase involved in DNA damage response and repair. We found that POLQ is overexpressed in NSCLC and is clinically correlated with high tumor stage, poor prognosis, increased tumor mutational burden, and ALK and TP5 mutation status; POLQ inhibition impaired lung tumorigenesis. Notably, POLQ expression was higher in radioresistant lung cancer cells than in wild‐type cancer cells. Moreover, POLQ expression was further increased in radioresistant cells after radiation. Enhanced radioresistance is through a prolonged G2/M phase and faster repair of DNA damage, leading to reduced radiation‐induced apoptosis. Novobiocin (NVB), a POLQ inhibitor, specifically targeted cancer cells. Genetic knockdown of POLQ or pharmacological inhibition by NVB decreased radioresistance in lung adenocarcinoma while causing little toxicity to normal pulmonary epithelial cells. In conclusion, POLQ is a promising and practical cancer‐specific target to impair tumorigenesis and enhance radiosensitivity in NSCLC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Institute of Radiation Oncology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Department of Thoracic Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Department of Pathology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
ORCID-Profile: Rui Zhou
Förderung
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
Zitieren
APA
Rao, X., Xing, B., Wu, Z., Bin, Y., Chen, Y., Xu, Y., Zhou, D., Zhou, X., Wu, C., Ye, W., Chen, W., Wang, G., Zhang, S., Dong, X., Meng, R., Wu, G., & Zhou, R. (2023). Targeting polymerase θ impairs tumorigenesis and enhances radiosensitivity in lung adenocarcinoma. Cancer Science. https://doi.org/10.1111/cas.15727
Vancouver
Rao X, Xing B, Wu Z, Bin Y, Chen Y, Xu Y, et al. Targeting polymerase θ impairs tumorigenesis and enhances radiosensitivity in lung adenocarcinoma. Cancer Science. 2023. doi:10.1111/cas.15727
BibTeX
@article{Rao2023,
author = {Rao, Xinrui and Xing, Biyuan and Wu, Zilong and Bin, Yawen and Chen, Yunshang and Xu, Yingzhuo and Zhou, Dong and Zhou, Xiaoshu and Wu, Chuangyan and Ye, Wang and Chen, Weibin and Wang, Geng and Zhang, Sheng and Dong, Xiaorong and Meng, Rui and Wu, Gang and Zhou, Rui},
title = {Targeting polymerase θ impairs tumorigenesis and enhances radiosensitivity in lung adenocarcinoma},
journal = {Cancer Science},
year = {2023},
doi = {10.1111/cas.15727}
}
EUVIMED